Umberto Maria Battisti

ORCID: 0000-0002-1012-8644
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Click Chemistry and Applications
  • Radiopharmaceutical Chemistry and Applications
  • Monoclonal and Polyclonal Antibodies Research
  • Chemical Synthesis and Analysis
  • Medical Imaging Techniques and Applications
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Chemical Reactions and Isotopes
  • Receptor Mechanisms and Signaling
  • Neuroscience and Neuropharmacology Research
  • Synthesis and Biological Evaluation
  • Parkinson's Disease Mechanisms and Treatments
  • Pharmacological Receptor Mechanisms and Effects
  • Analytical Chemistry and Chromatography
  • HER2/EGFR in Cancer Research
  • Alzheimer's disease research and treatments
  • Crystallization and Solubility Studies
  • Neuropeptides and Animal Physiology
  • Advanced biosensing and bioanalysis techniques
  • X-ray Diffraction in Crystallography
  • Synthesis and biological activity
  • Molecular spectroscopy and chirality
  • Peptidase Inhibition and Analysis
  • Quinazolinone synthesis and applications
  • bioluminescence and chemiluminescence research
  • Chemical Reaction Mechanisms

University of Copenhagen
2020-2025

TetraPlan
2024

KTH Royal Institute of Technology
2023-2024

Science for Life Laboratory
2023-2024

University of Gothenburg
2022-2024

University of Modena and Reggio Emilia
2010-2022

Virginia Commonwealth University
2015-2021

Azienda Unita' Sanitaria Locale Di Modena
2016

The development of highly selective and fast biocompatible reactions for ligation cleavage has paved the way new diagnostic therapeutic applications pretargeted in vivo chemistry. concept bioorthogonal pretargeting attracted considerable interest, particular targeted delivery radionuclides drugs. In nuclear medicine, can provide increased target-to-background ratios at early time-points compared to traditional approaches. This reduces radiation burden healthy tissue and, depending on...

10.1021/acsptsci.1c00007 article EN cc-by-nc-nd ACS Pharmacology & Translational Science 2021-02-16

Pretargeted PET imaging is an emerging and fast-developing method to monitor immuno-oncology strategies. Currently, tetrazine ligation considered the most promising bioorthogonal reaction for pretargeting in vivo. Recently, we have developed a 18F-label ultrareactive tetrazines by copper-mediated fluorinations. However, bispyridyl tetrazines-one of structures vivo pretargeted applications-were inaccessible using this strategy. We believed that our successful efforts H-tetrazines low basic...

10.3390/ph15020245 article EN cc-by Pharmaceuticals 2022-02-18

Abstract Introduction Cannabis sativa L. is a powerful medicinal plant and its use has recently increased for the treatment of several pathologies. Nonetheless, side effects, like dizziness hallucinations, long‐term effects concerning memory cognition, can occur. Most alarming lack standardised procedure to extract cannabis. Indeed, each galenical preparation an unknown chemical composition in terms cannabinoids other active principles that depends on extraction procedure. Objective This...

10.1002/pca.2722 article EN Phytochemical Analysis 2017-09-15

Pretargeted imaging of nanomedicines have attracted considerable interest because it has the potential to increase contrast while reducing radiation burden healthy tissue. Currently, tetrazine ligation is fastest bioorthogonal reaction for this strategy and, consequently, state-of-art choice in vivo chemistry. We recently identified key properties tetrazines pretargeting. also developed a method 18F-label reactive using an aliphatic nucleophilic substitution strategy. Here, we combined...

10.1021/acs.jmedchem.1c01326 article EN Journal of Medicinal Chemistry 2021-10-15

Pretargeted radioimmunoimaging has been shown to enhance tumor-to-background ratios by up 125-fold at early time points, leading more efficient and less toxic radionuclide therapies, particularly with shorter half-lives such as astatine-211 (211At). The tetrazine ligation is the most utilized bioorthogonal reaction in these strategies, making tetrazines ideal for 211At labeling controlling biodistribution. We developed a 211At-labeled pretargeting agent alpha-radionuclide therapy, achieving...

10.1021/acs.jmedchem.4c02281 article EN Journal of Medicinal Chemistry 2025-02-18

Pretargeted imaging harnessing tetrazine ligation has gained increased interest over recent years. Targeting vectors with slow pharmacokinetics may be visualized using short-lived radionuclides, such as fluorine-18 (18F) for positron emission tomography (PET), and result in improved target-to-background ratios compared to conventionally radiolabeled slowly accumulating vectors. We recently developed different radiochemical protocols enabling the direct radiofluorination of various scaffolds,...

10.1021/acs.molpharmaceut.4c01129 article EN cc-by-nc-nd Molecular Pharmaceutics 2025-03-13

Tetrazines (Tz) have been applied as bioorthogonal agents for various biomedical applications, including pretargeted imaging approaches. In radioimmunoimaging, pretargeting increases the target-to-background ratio while simultaneously reducing radiation burden. We recently reported a strategy to directly 18F-label highly reactive tetrazines based on 3-(3-fluorophenyl)-Tz core structure. Herein, we report kinetic study this versatile scaffold. A library of 40 different was prepared, fully...

10.1021/acs.bioconjchem.2c00042 article EN cc-by-nc-nd Bioconjugate Chemistry 2022-03-15

Pretargeting is a powerful nuclear imaging strategy to achieve enhanced contrast for nanomedicines and reduce the radiation burden healthy tissue. based on bioorthogonal chemistry. The most attractive reaction this purpose currently tetrazine ligation, which occurs between trans-cyclooctene (TCO) tags tetrazines (Tzs). Pretargeted beyond blood-brain barrier (BBB) challenging has not been reported thus far. In study, we developed Tz agents that are capable of ligating in vivo targets BBB. We...

10.1039/d2md00360k article EN cc-by RSC Medicinal Chemistry 2022-12-02

Liver pyruvate kinase (PKL) has recently emerged as a new target for non-alcoholic fatty liver disease (NAFLD), and inhibitors of this enzyme could represent therapeutic option. However, breakthrough is complicated by selectivity issues since exists in four different isoforms. In work, we report that ellagic acid (EA) its derivatives, present numerous fruits vegetables, can inhibit PKL potently selectively. Several polyphenolic analogues EA were synthesized tested to identify the chemical...

10.3390/nu15030577 article EN Nutrients 2023-01-22

Aliphatic nucleophilic substitution (SN2) with [18F]fluoride is the most widely applied method to prepare 18F-labeled positron emission tomography (PET) tracers. Strong basic conditions commonly used during 18F-labeling procedures inherently limit or prohibit labeling of base-sensitive scaffolds. The high basicity stems from tradition trap on anion exchange cartridges and elute it afterward anions. This sequence facilitate transfer an aqueous aprotic organic, polar reaction medium, which...

10.1021/acsptsci.1c00133 article EN cc-by-nc-nd ACS Pharmacology & Translational Science 2021-08-12

Abstract A set of 211 At‐astatoarenes were synthesized from corresponding trimethylgermyl arenes with an average radiochemical conversion (RCC) ca. 50 % for electron‐rich and approx. 70 in case electron‐deficient arenes. Both electron rich poor substrates successfully radiolabeled at room temperature (RT) using relatively low precursor amounts (0.15 μmol/0.02 mL solvent (7.5 mM)). Ready access to ortho‐, para‐ meta‐ astatinated was achievable. Optimized reaction conditions applied label a...

10.1002/cplu.202400254 article EN cc-by ChemPlusChem 2024-06-15

Brain pretargeted nuclear imaging for the diagnosis of various neurodegenerative diseases is a quickly developing field. The tetrazine ligation currently most explored approach to achieve this goal due its remarkable properties. In work, we evaluated performance F-537-Tetrazine, previously developed by Biogen, and N-(3-[18F]fluoro-5-(1,2,4,5-tetrazin-3-yl)benzyl)propan-1-amine, in our group, thereby allowing direct comparison these two probes. evaluation included synthesis, radiolabeling...

10.1016/j.nucmedbio.2024.108877 article EN cc-by Nuclear Medicine and Biology 2024-01-01

Radiolabeling of tetrazines has gained increasing attention due to their important role in pretargeted imaging or therapy. The most commonly used radionuclide PET is fluorine-18. For this reason, we have recently developed a method which enables the direct aromatic 18F-fluorination using stannane precursors through copper-mediated fluorinations. Herein, further optimized labeling procedure. 3-(3-fluorophenyl)-1,2,4,5-tetrazine was chosen for purpose because its high reactivity and respective...

10.3390/molecules27134022 article EN cc-by Molecules 2022-06-22

The inhibition of liver pyruvate kinase could be beneficial to halt or reverse non-alcoholic fatty disease (NAFLD), a progressive accumulation fat in the that can lead eventually cirrhosis. Recently, urolithin C has been reported as new scaffold for development allosteric inhibitors (PKL). In this work, comprehensive structure–activity analysis was carried out. More than 50 analogues were synthesized and tested regarding chemical features responsible desired activity. These data pave way...

10.3390/ph16050668 article EN cc-by Pharmaceuticals 2023-04-28

Small-molecular fibroblast activation protein inhibitor (FAPI)-based tracer have been shown to be promising Positron Emission Tomography (PET) 68Ga-labeled radiopharmaceuticals image a variety of tumors including pancreatic, breast, and colorectal cancers, among others. In this study, we developed novel 18F-labeled FAPI derivative. [18F]6 was labeled using synthon approach based on the tetrazine ligation. It showed subnanomolar affinity for FAP good selectivity profile against known...

10.1016/j.ejmech.2023.115862 article EN cc-by European Journal of Medicinal Chemistry 2023-10-14

The potential therapeutic benefit of compounds able to activate AMPA receptors (AMPAr) has led the search for new AMPAr positive modulators. On basis crystallographic data benzothiadiazines binding mode in S1S2 GluA2 dimer interface, a set 5-aryl-2,3-dihydrobenzothiadiazine type been synthesized and tested. Electrophysiological results suggested that 5-heteroaryl substituents on benzothiadiazine core like 3-furanyl 3-thiophenyl dramatically enhance activity as modulators with respect IDRA21...

10.1021/ml200184w article EN ACS Medicinal Chemistry Letters 2011-11-15
Coming Soon ...